Analysis Tools
growth/size/body
 |
• in females prior to tamoxifen treatment
|
skeleton
short femur
(
J:189512
)
|
|
• in females after tamoxifen treatment
|
|
|
• decrease in vertebral height in females after tamoxifen treatment
|
|
• increase in osteoclast surface in the femoral metaphysis in tamoxifen treated males and females
|
|
|
• in tamoxifen treated females
|
|
|
• decreased bone mineral density in the femur of females after tamoxifen treatment
|
|
|
• in the distal femora and lumbar vertebrae in tamoxifen treated females
|
|
|
• in tamoxifen treated females
|
|
• decrease in the mineral apposition rate in the distal femoral metaphysis of tamoxifen treated males and females
• cancellous bone formation rate and mid-femoral endocortical MAR are decreased in tamoxifen treated females
|
|
|
• reduced mean polar moment of inertia in tamoxifen treated females
|
hematopoietic system
|
• increase in osteoclast surface in the femoral metaphysis in tamoxifen treated males and females
|
|
|
• in tamoxifen treated females
|
immune system
|
• increase in osteoclast surface in the femoral metaphysis in tamoxifen treated males and females
|
|
|
• in tamoxifen treated females
|
limbs/digits/tail
short femur
(
J:189512
)
|
|
• in females after tamoxifen treatment
|
